These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4973676)

  • 41. [Sensitivity "in vitro" of human tubercular mycobacteria and atypical mycobacteria to rifampicin].
    Mandler F; Garimoldi M
    G Ital Mal Torace; 1969; ():Suppl 2:7-13. PubMed ID: 4982435
    [No Abstract]   [Full Text] [Related]  

  • 42. Mode of action of antituberculous agents and ultrastructure of mycobacteria.
    Oka S; Yamaguchi J; Ariji F; Madokoro K; Kumano N
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):7-13. PubMed ID: 5005200
    [No Abstract]   [Full Text] [Related]  

  • 43. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pharmacokinetics of rifomycin].
    Curci G; Ninni A; Iodice F
    Acta Tuberc Pneumol Belg; 1969; 60(3):276-87. PubMed ID: 5371665
    [No Abstract]   [Full Text] [Related]  

  • 45. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2005 Oct; 251(1):19-22. PubMed ID: 16143463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experimental study on the antitubercular activity of butomelide].
    Pershin GN; Zykova TN
    Probl Tuberk; 1972; 50(7):60-3. PubMed ID: 4626206
    [No Abstract]   [Full Text] [Related]  

  • 47. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Activity of Rifampicin associated with other drugs on experimental tuberculosis in guinea pigs].
    Nitti V; Ninni A
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):871-95. PubMed ID: 5304754
    [No Abstract]   [Full Text] [Related]  

  • 50. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 51. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Primary drug resistance in tuberculosis].
    Naito M; Shinoda A; Aoyagi A; Osato T; Nakai H
    Kekkaku; 1968 Aug; 43(8):343-58. PubMed ID: 4975161
    [No Abstract]   [Full Text] [Related]  

  • 53. [Rifampicin in the intermittent treatment of experimental tuberculosis in mice].
    Lucchesi M; Matzeu M; Mancini P
    G Ital Mal Torace; 1971; 25(6):313-8. PubMed ID: 5005063
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of kanamycin in vitro on the growth of tuberculosis bacillus and in vitro on experimental tuberculosis of Guinea pigs].
    Durisić M; Drndarski K
    Glas Srp Akad Nauka Med; 1967; (20):101-7. PubMed ID: 4970999
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.
    Pattyn SR
    Arzneimittelforschung; 1982; 32(1):15-7. PubMed ID: 7037013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 59. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
    Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
    Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
    Sood R; Rao M; Singhal S; Rattan A
    Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.